Login
Toggle sidebar

Lint: ewsr1-smad3-positive-fibroblastic-tumour

ewsr1-smad3-positive-fibroblastic-tumour
Strong List Colon Position
error

"T1: hypointense"

Line 45:8 · When enboldening an intro, the colon should not be bold. '<strong>T1:</strong> hypointense'

"T2: hyperintense"

Line 46:8 · When enboldening an intro, the colon should not be bold. '<strong>T2:</strong> hyperintense'
Emphasis
warning

"EWSR1-SMAD3-positive fibroblastic tumours are benign mesenchymal neoplasms with different morphologies and a provisional name 1-4 that was and added to the WHO classification of soft tissue tumours in 2020 2,3."

Line 1:12 · Italics should be used only in exceptional circumstances: '<em>EWSR1-SMAD3</em>'

"EWSR1-SMAD3-positive fibroblastic tumours are sporadic soft tissue neoplasms. They appear in a wide age range, with women more commonly affected than men 2."

Line 3:4 · Italics should be used only in exceptional circumstances: '<em>EWSR1-SMAD3</em>'

"The diagnosis of EWSR1-SMAD3-positive fibroblastic tumours is established by location, histological, immunohistochemical, and molecular criteria 1."

Line 5:21 · Italics should be used only in exceptional circumstances: '<em>EWSR1-SMAD3</em>'

"EWSR1-SMAD3 fusion"

Line 14:12 · Italics should be used only in exceptional circumstances: '<em>EWSR1-SMAD3</em>'

"EWSR1-SMAD3-positive fibroblastic tumours usually present as painless, small, superficial nodules in an acral location in the hands and/or feet 1,3."

Line 16:4 · Italics should be used only in exceptional circumstances: '<em>EWSR1-SMAD3</em>'

"EWSR1-SMAD3-positive fibroblastic tumours are characterised by a zonal morphology of intersecting cellular fascicles composed of monomorphic spindle cells and hypo to acellular hyalinised areas 1-4."

Line 18:4 · Italics should be used only in exceptional circumstances: '<em>EWSR1-SMAD3</em>'

"EWSR1-SMAD3-positive fibroblastic tumours are most commonly located in the skin or the subcutaneous tissue of the hands and feet 1-4."

Line 22:4 · Italics should be used only in exceptional circumstances: '<em>EWSR1-SMAD3</em>'

"Histologically EWSR1-SMAD3-positive fibroblastic tumours display the following characteristics 1-4:"

Line 26:19 · Italics should be used only in exceptional circumstances: '<em>EWSR1-SMAD3</em>'

"Those tumours are characterised by genetic EWSR1-SMAD3 fusions 1."

Line 36:46 · Italics should be used only in exceptional circumstances: '<em> EWSR1-SMAD3 </em>'

"EWSR1-SMAD3-positive fibroblastic tumours have been first described by the Taiwanese pathologist Yu-Chien Kao and his American and Dutch colleagues Lei Zhang, Yun-Shao Sung, Albert JH Suurmeijer and Cristina R Antonescu 1."

Line 59:4 · Italics should be used only in exceptional circumstances: '<em>EWSR1-SMAD3</em>'

"Conditions that can mimic the presentation and/or the appearance of EWSR1-SMAD3-positive fibroblastic tumours include the following:"

Line 61:72 · Italics should be used only in exceptional circumstances: '<em>EWSR1-SMAD3</em>'
Strong
warning

"EWSR1-SMAD3-positive fibroblastic tumours are sporadic soft tissue neoplasms. They appear in a wide age range, with women more commonly affected than men 2."

Line 3:25 · Generally, don't use bold in text: 'positive fibroblastic tumours are sporadic soft tissue neoplasms. They<strong> </strong>appear in a wide age range, with women more commonly affected than men'

"The diagnosis of EWSR1-SMAD3-positive fibroblastic tumours is established by location, histological, immunohistochemical, and molecular criteria 1."

Line 5:42 · Generally, don't use bold in text: 'positive fibroblastic tumours<strong> </strong>is established by location, histological, immunohistochemical, and molecular criteria'
Acronyms
warning

"immunoreactivity to ERG"

Line 11:28 · 'ERG' has no definition. Spell it out if it's unfamiliar to the audience.

"Immunohistochemistry stains show diffuse nuclear reactivity for ERG, but do not express CD34 or smooth muscle actin 1,2,4."

Line 34:75 · 'ERG' has no definition. Spell it out if it's unfamiliar to the audience.

"EWSR1-SMAD3-positive fibroblastic tumours have been first described by the Taiwanese pathologist Yu-Chien Kao and his American and Dutch colleagues Lei Zhang, Yun-Shao Sung, Albert JH Suurmeijer and Cristina R Antonescu 1."

Line 59:236 · 'JH' has no definition. Spell it out if it's unfamiliar to the audience.
Headings Valid
warning

Expected headings

  • H1 Terminology
  • H1 Usage
  • H1 Epidemiology
  • H2 Risk factors
  • H2 Associations
  • H1 Clinical presentation
  • H2 Complications
  • H1 Diagnosis
  • H2 Diagnostic criteria
  • H2 Diagnostic clues
  • H1 Pathology
  • H2 Aetiology
  • H2 Location
  • H2 Classification
  • H2 Macroscopic appearance
  • H2 Microscopic appearance
  • H2 Immunophenotype
  • H2 Markers
  • H2 Genetics
  • H1 Radiographic features
  • H2 Plain radiograph
  • H2 Mammography
  • H2 Antenatal ultrasound
  • H2 Transoesophageal echocardiography
  • H2 Ultrasound
  • H2 CT
  • H3 Dual-energy CT
  • H2 Angiography (DSA)
  • H2 MRI
  • H2 CT/MRI
  • H2 Nuclear medicine
  • H3 PET-CT
  • H3 PET-MRI
  • H1 Radiology report
  • H1 Treatment and prognosis
  • H2 Complications
  • H1 History and etymology
  • H1 Differential diagnosis
  • H2 Clinical differential diagnosis
  • H1 Practical points
  • H1 See also

"Signal characteristics"

Line 43:1 · "Signal characteristics" is not a recognised heading for this article type.
Oxford Comma
suggestion

"absence of nuclear pleomorphism, hyperchromasia and increased mitotic activity"

Line 30:27 · Use the Oxford comma in 'pleomorphism, hyperchromasia and increased'.
Biographical Lifespan
suggestion

"History and etymology"

Line 58:1 · A bold element in the History and etymology section should be a person; it would be useful to have their lifespan details: '<h4>History and etymology</h4> <p><em>EWSR1-SMAD3</em>-positive fibroblastic tumours have been first described by the Taiwanese pathologist <strong>Yu-Chien Kao</strong> '
Links
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0